These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18188508)

  • 1. Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?
    Good AC; Oprea TI
    J Comput Aided Mol Des; 2008; 22(3-4):169-78. PubMed ID: 18188508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community benchmarks for virtual screening.
    Irwin JJ
    J Comput Aided Mol Des; 2008; 22(3-4):193-9. PubMed ID: 18273555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?
    Kirchmair J; Markt P; Distinto S; Wolber G; Langer T
    J Comput Aided Mol Des; 2008; 22(3-4):213-28. PubMed ID: 18196462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments.
    Good AC; Hermsmeier MA; Hindle SA
    J Comput Aided Mol Des; 2004; 18(7-9):529-36. PubMed ID: 15729852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and optimization of virtual screening workflows with DEKOIS 2.0--a public library of challenging docking benchmark sets.
    Bauer MR; Ibrahim TM; Vogel SM; Boeckler FM
    J Chem Inf Model; 2013 Jun; 53(6):1447-62. PubMed ID: 23705874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics.
    Armstrong MS; Morris GM; Finn PW; Sharma R; Moretti L; Cooper RI; Richards WG
    J Comput Aided Mol Des; 2010 Sep; 24(9):789-801. PubMed ID: 20614163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual decoy sets for molecular docking benchmarks.
    Wallach I; Lilien R
    J Chem Inf Model; 2011 Feb; 51(2):196-202. PubMed ID: 21207928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring CAMD technique performance. 2. How "druglike" are drugs? Implications of Random test set selection exemplified using druglikeness classification models.
    Good AC; Hermsmeier MA
    J Chem Inf Model; 2007; 47(1):110-4. PubMed ID: 17238255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLAP: GRID molecular interaction fields in virtual screening. validation using the DUD data set.
    Cross S; Baroni M; Carosati E; Benedetti P; Clementi S
    J Chem Inf Model; 2010 Aug; 50(8):1442-50. PubMed ID: 20690627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening in lead discovery and optimization.
    Jain AN
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening.
    Liu X; Jiang H; Li H
    J Chem Inf Model; 2011 Sep; 51(9):2372-85. PubMed ID: 21819157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS data.
    Lindh M; Svensson F; Schaal W; Zhang J; Sköld C; Brandt P; Karlén A
    J Chem Inf Model; 2015 Feb; 55(2):343-53. PubMed ID: 25564966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of molecular fingerprint similarity search in virtual screening.
    Muegge I; Mukherjee P
    Expert Opin Drug Discov; 2016; 11(2):137-48. PubMed ID: 26558489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROCS-derived features for virtual screening.
    Kearnes S; Pande V
    J Comput Aided Mol Des; 2016 Aug; 30(8):609-17. PubMed ID: 27624668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success.
    Good AC; Cheney DL; Sitkoff DF; Tokarski JS; Stouch TR; Bassolino DA; Krystek SR; Li Y; Mason JS; Perkins TD
    J Mol Graph Model; 2003 Sep; 22(1):31-40. PubMed ID: 12798389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor.
    Vass M; Jójárt B; Bogár F; Paragi G; Keserű GM; Tarcsay Á
    J Comput Aided Mol Des; 2015 Dec; 29(12):1137-49. PubMed ID: 26572911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.